Peabody Energy Corp New
NYSE: BTU
$25.99
-$1.42 (-5.2%)
Closing Price on November 25, 2024
BTU Articles
These are ten of the individual analyst calls seen out there this Thursday morning ahead of a 3-day weekend: Aetna (NYSE: AET) cut to Sell at Goldman Sachs. Alcoa (NYSE: AA) Raised from Sell to Hold...
Published:
These are ten of the analyst calls we are focusing on this Wednesday morning: Alaska Communications (NASDAQ: ALSK) Raised to Buy at Banc Of America Securities. Amylin Pharmaceuticals (NASDAQ: AMLN)...
Published:
On Monday, Peabody Energy (NYSE:BTU) announced strong first quarter results: 15% increase in revenue to a record $1.28 billion and EPS from continuing operations of $0.26. Peabody raised its...
Published:
Below are the top research calls that a673b.bigscoots-temp.com is focusing on: Aventine Renewable Energy (NYSE: AVR) downgraded to Sell from Hold at Soleil. Genentech (NYSE: DNA) raised to Outperform at Rodman...
Published:
Goldman Sachs has downgraded its coverage in Coal Stocks this morning. Goldman Sachs is basing this partly on the 30% gains seen, and valuations are stretched. There were several downgraded from...
Published:
This morning we have another ETF being launched that is quite sector specific. Van Eck Associated has listed the Market Vectors Coal ETF (NYSE: KOL). While we have noted some ETF’s being too...
Published:
These are not the only impacting analyst calls this morning, but these are most of the initial calls being focused on by a673b.bigscoots-temp.com: Digital River (DRIV) raised to Outperform from Neutral at...
Published:
ACI cut to Hold at Citigroup.AKAM started as Outperform at FBR.BAGL started as Outperform at Piper Jaffray.BTU cut to Hold at Citigroup.CPB raised to Outperform at Bernstein.DAC started as Outperform...
Published:
AMR raised to Neutral at UBS.BEAS raised to Outperform at Credit Suisse.BHP cut to Hold at Deutsche Bank.BTU cut to Neutral at HSBC.COGN raised to Strong Buy at JMP Securities.CPA raised to...
Published:
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
Published:
Stock Tickers: ACI, CNX, BTU Tonight on CNBC’s Mad Money, Jim Cramer said that recent pushes out of Democrats are now backing new coal initiatives for coal and for converting coal to fuel. Since...
Published: